The purpose of this study was to determine the 2-year impact of a worksite-based diabetes prevention program. Thirty-seven pre-diabetic and previously undiagnosed diabetic employees participating in a 12-month worksite diabetes prevention program were included. Weight, body mass index, waist circumference, oral glucose tolerance testing, fasting insulin, blood lipids, and aerobic fitness had improved significantly after 6 months. Much of this improvement continued through 12 months. One year following the intervention, oral glucose tolerance and aerobic fitness had improved significantly. Of the 22 employees remaining in the study through 24 months, more than half had normal results on glucose tolerance testing. Worksite diabetes prevention programs may reduce blood glucose below pre-diabetic and diabetic levels. Improvements in diabetes risk factors persisted for at least 2 years in most of these employees.
References
1.
AldanaS.BarlowM.SmithR.YanowitzF.AdamsT.LovedayL. (2005). A worksite experience with the diabetes prevention program. AAOHN Journal, 53(11), 499–505.
2.
American College of Sports Medicine. (1995). ACSM's guidelines for exercise testing and prescription (6th ed.). Philadelphia: Lippincott Williams & Wilkins.
3.
American Diabetes Association. (2004). Screening for type 2 diabetes. Diabetes Care, 27(Suppl. 1), S11–S14.
4.
Centers for Disease Control and Prevention. (2004). Behavioral Risk Factor Surveillance System. Retrieved June 1, 2004, from www.cdc.gov/brfss.
5.
DishmanR. K.OldenburgB.O'NealH.ShephardR. J. (1998). Worksite physical activity interventions. American Journal of Preventive Medicine, 15(4), 344–361.
6.
EdelsteinS. L.KnowlerW. C.BainR. P.AndresR.Barrett-ConnorE. L.DowseG. K. (1997). Predictors of progression from impaired glucose tolerance to NIDDM: An analysis of six prospective studies. Diabetes, 46(4), 701–710.
7.
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. (2002). American Diabetes Association: Clinical practice recommendations 2002. Diabetes Care, 25(Suppl. 1), S1–147.
8.
FranzM. J.HortonE. S.Sr.BantleJ. P.BeebeC. A.BrunzellJ. D.CoulstonA. M. (1994). Nutrition principles for the management of diabetes and related complications. Diabetes Care, 17(5), 490–518.
9.
HammanR. F. (1992). Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). Diabetes/Metabolism Research and Reviews, 8(4), 287–338.
10.
JohnsonJ. M.BallinS. D. (1996). Surgeon General's report on physical activity and health is hailed as a historic step toward a healthier nation. Circulation, 94(9), 2045.
11.
KiernanM.WinklebyM. A. (2000). Identifying patients for weight-loss treatment: An empirical evaluation of the NHLBI obesity education initiative expert panel treatment recommendations. Archives of Internal Medicine, 160(14), 2169–2176.
12.
KnowlerW. C.Barrett-ConnorE.FowlerS. E.HammanR. F.LachinJ. M.WalkerE. A. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346(6), 393–403.
13.
KosakaK.NodaM.KuzuyaT. (2005). Prevention of type 2 diabetes by lifestyle intervention: A Japanese trial in IGT males. Diabetes Research and Clinical Practice, 67(2), 152–162.
14.
LefebvreP.PiersonA. (2004). The global challenge of diabetes. World Hospitals and Health Services, 40(3), 37–40, 42.
15.
LindstromJ.PeltonenM.TuomilehtoJ. (2005). Lifestyle strategies for weight control: Experience from the Finnish Diabetes Prevention Study. Proceedings of the Nutrition Society, 64(1), 81–88.
16.
LiptonR. B.LiaoY.CaoG.CooperR. S.McGeeD. (1993). Determinants of incident non-insulin-dependent diabetes mellitus among blacks and whites in a national sample: The NHANES I Epidemiologic Follow-up Study. American Journal of Epidemiology, 138(10), 826–839.
17.
MollerD. E.FlierJ. S. (1991). Insulin resistance: Mechanisms, syndromes, and implications. New England Journal of Medicine, 325(13), 938–948.
18.
NarayanK. M.BoyleJ. P.ThompsonT. J.SorensenS. W.WilliamsonD. F. (2003). Lifetime risk for diabetes mellitus in the United States. Journal of the American Medical Association, 290(14), 1884–1890.
19.
PanX. R.LiG. W.HuY. H.WangJ. X.YangW. Y.AnZ. X. (1997). Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: The Da Qing IGT and Diabetes Study. Diabetes Care, 20(4), 537–544.
20.
PearsonT. L.PronkN. P.TanA. W.HalstensonC. (2003). Identifying individuals at risk for the development of type 2 diabetes mellitus. American Journal of Managed Care, 9(1), 57–66.
21.
PeetersA.BarendregtJ. J.WillekensF.MackenbachJ. P.Al MamunA.BonneuxL. (2003). Obesity in adulthood and its consequences for life expectancy: A life-table analysis. Annals of Internal Medicine, 138(1), 24–32.
22.
RolkaD. B.NarayanK. M.ThompsonT. J.GoldmanD.LindenmayerJ.AlichK. (2001). Performance of recommended screening tests for undiagnosed diabetes and dysglycemia. Diabetes Care, 24(11), 1899–1903.
23.
ShakespeareW. (1623). King Henry the Fourth, Part II. (King Henry at V, v).
24.
TuomilehtoJ.LindstromJ.ErikssonJ. G.ValleT. T.HamalainenH.Ilanne-ParikkaP. (2001). Finnish Diabetes Prevention Study Group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine, 344(18), 1343–1350.
